APA (7th ed.) Citation

AM, S., S, T., A, S., H, T., V, F., B, P., . . . N, F. (2025). AZ14289671 is a highly selective and blood-brain barrier penetrant irreversible TKI that targets EGFRExon20 insertions. Cell reports. Medicine, 6(9), 102305. https://doi.org/10.1016/j.xcrm.2025.102305

Chicago Style (17th ed.) Citation

AM, Swaih, et al. "AZ14289671 Is a Highly Selective and Blood-brain Barrier Penetrant Irreversible TKI That Targets EGFRExon20 Insertions." Cell Reports. Medicine 6, no. 9 (2025): 102305. https://doi.org/10.1016/j.xcrm.2025.102305.

MLA (9th ed.) Citation

AM, Swaih, et al. "AZ14289671 Is a Highly Selective and Blood-brain Barrier Penetrant Irreversible TKI That Targets EGFRExon20 Insertions." Cell Reports. Medicine, vol. 6, no. 9, 2025, p. 102305, https://doi.org/10.1016/j.xcrm.2025.102305.